Table 2. Treatment characteristics.
Treatment characteristics including chemotherapy regimen and radiotherapy schedule.
| No | Chemotherapy | Response after CTx | Recur | ||
|---|---|---|---|---|---|
| 1 | - | CSI | CSI 19.5 Gy+WB 18 Gy+Local 7.5 Gy | - | |
| 2 | - | CSI | CSI 19.5 Gy+WB 18 Gy+Local 12 Gy | - | |
| 3 | - | CSI | CSI 34.2 Gy+Local 20 Gy | - | |
| 4 | DDP/Etoposide/Bleomycin #4 | CR | Local field RT | Local 19.8 Gy | Yes |
| 5 | - | CSI | CSI 19.5 Gy+Local 19.8 Gy | Yes | |
| 6 | - | CSI | CSI 19.5 Gy+Local 19.8 Gy | - | |
| 7 | DDP/Etoposide #2 | CR | CSI | CSI 19.5 Gy+Local 19.8 Gy | - |
| 8 | - | CSI | CSI 19.5 Gy+Local 19.8 Gy | - | |
| 9 | DDP/Etoposide #4 | PR | CSI | CSI 24.6 Gy+Local 16.2 Gy | - |
| 10 | - | CSI | CSI 19.5 Gy+Local 19.8 Gy | - | |
| 11 | Carboplatin/Etoposide/Cyclophosphamide #6 | PR | CSI | CSI 19.5 Gy+Local 19.8 Gy | - |
| 12 | - | CSI | CSI 24 Gy+Local 16.2 Gy | - | |
| 13 | Carboplatin/Etoposide/Cyclophosphamide #6 | CR | WVRT | WV 19.8 Gy+Local 10.8 Gy | - |
| 14 | - | CSI | CSI 24 Gy+Local 21.6 Gy | - | |
| 15 | Carboplatin/Etoposide/Cyclophosphamide #4 | PR | WVRT | WV 19.8 Gy+Local 10.8 Gy | - |
| 16 | - | CSI | CSI 19.5 Gy+Local 16 Gy | - | |
| 17 | - | CSI | CSI 19.5 Gy+Local 16 Gy | - | |
| 18 | - | CSI | CSI 19.5 Gy+Local 16 Gy | - | |
| 19 | - | CSI | CSI 18 Gy+Local 18 Gy | - | |
| 20 | - | WVRT | WV 18 Gy+Local 18 Gy | Yes | |
| 21 | - | CSI | CSI 18 Gy+Local 18 Gy | - |
Abbreviations: CTx, chemotherapy; CR, complete response; PR, partial response; CSI, cranio-spinal irradiation; RT, radiotherapy; WVRT, whole ventricle radiotherapy; WB, whole brain.